Skip to main content

Company News

  • February 27, 2023

    2022: a fruitful year of CSR achievements

    We are committed to play our part and as every gesture counts to change the game, we have implemented a number of concrete actions in line with our CSR objectives.
  • February 21, 2023

    bioMérieux launches a PCR kit for detection of the monkeypox virus

    bioMérieux has developed a MONKEYPOX R-GENE® PCR kit. Available for research use only (RUO), this kit can easily be used by laboratories around the world.
  • January 17, 2023

    18 Top Employer certifications for bioMérieux!

    These certifications demonstrate the quality of our HR strategy and rewards the commitment of our HR teams who work every day to improve the employee experience at bioMérieux! The Top Employer seal also impacts our attractiveness by telling candidates that we care about our people!
  • January 04, 2023

    bioMérieux establishes Antimicrobial Stewardship Centers of Excellence

    bioMérieux takes a proactive, partnership-driven approach to combating AMR with diagnostic and data-driven solutions to improve stewardship efforts. To further this goal, bioMérieux created the AMS Centers of Excellence (CoE) designation awarded to hospitals around the world as a sign of a joint commitment to best AMS practices.
  • December 08, 2022

    Cell and Gene Therapies: bioMérieux partners with NecstGen

    bioMérieux and NecstGen, collaborate to accelerate the development of Cell and Gene Therapies (CGT) through the provision of ‘state of the art’ and rapid quality and safety testing technologies that will allow safe and effective advanced therapeutics production.